Vistagen Therapeutics (VTGN) Accumulated Expenses (2011 - 2026)
Vistagen Therapeutics (VTGN) reported Accumulated Expenses of $9.24 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 40.4% from $6.58 million a year earlier and up 5.5% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Accumulated Expenses of $8.76 million, down 0.6% from FY2025.
- Accumulated Expenses has a five-year compound annual growth rate of 41.1% (FY2021 to FY2026).
- By fiscal year, Accumulated Expenses came in at $8.81 million in FY2025 (+294.2%), $2.24 million in FY2024 (+180.8%), $796,000 in FY2023 (-40.1%) and $1.33 million in FY2022 (-14.9%).
- Five-year quarterly Accumulated Expenses spans a low of $129,300 in fiscal Q3 2024 and a high of $9.25 million in fiscal Q3 2026.
- Year over year, Accumulated Expenses gained in five of the last six quarters, with growth averaging 121.3%.
- The high point for year-over-year Accumulated Expenses in five years was fiscal Q3 2022 (growth of 418.0%); the low point was fiscal Q3 2024 (a decline of 88.1%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $8.76 million (Q4 2026), $9.25 million (Q3 2026) and $8.42 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.24 Mn |
| Mar 31, 2026 | 8.76 Mn |
| Dec 31, 2025 | 9.25 Mn |
| Sep 30, 2025 | 8.42 Mn |
| Jun 30, 2025 | 6.58 Mn |
| Mar 31, 2025 | 8.81 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 129,300.00 |
| Sep 30, 2023 | 292,600.00 |
| Jun 30, 2023 | 424,700.00 |
| Mar 31, 2023 | 796,000.00 |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 727,300.00 |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 3.43 Mn |
API Access
Vistagen Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();